Jiro Fujita

InstitutionUniversity of the Ryukyus
AddressOkinawa
Japan
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 14 Covid-19 publications, with a maximum of 2 publications in October 2020 and March 2021
    All Publications
    Bar chart showing 354 publications over 20 distinct years, with a maximum of 35 publications in 2007
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Fujita J, Nakamura H, Miyagi K, Tateyama M. Subpleural Curvilinear Shadows Associated with COVID-19. Intern Med. 2021 Aug 01; 60(15):2505-2506. PMID: 34092732.
      Citations:    Fields:    Translation:Humans
    2. Kami W, Kinjo T, Arakaki W, Oki H, Motooka D, Nakamura S, Fujita J. Rapid and simultaneous identification of three mutations by the Novaplex™ SARS-CoV-2 variants I assay kit. J Clin Virol. 2021 Aug; 141:104877. PMID: 34134034.
      Citations: 3     Fields:    Translation:Humans
    3. Yamaniha K, Kinjo T, Akamine M, Setoguchi M, Tateyama M, Fujita J. False-positive for SARS-CoV-2 antigen test in a man with acute HIV infection. J Infect Chemother. 2021 Jul; 27(7):1112-1114. PMID: 33902991.
      Citations: 1     Fields:    Translation:Humans
    4. Chinen Y, Kinjyo Y, Mekaru K, Kinjo T, Higure Y, Kinjo T, Miyagi K, Yamada H, Masamoto H, Goya H, Yoshida T, Maeshiro S, Nakamatsu M, Fujita J, Aoki Y. Critical respiratory failure in pregnancy complicated with COVID-19: A case report. Case Rep Womens Health. 2021 Apr; 30:e00309. PMID: 33777708.
      Citations:    
    5. Kinjo T, Hokama A, Nakamura H, Miyagi K, Higure Y, Otsuki M, Nishiyama N, Nakamatsu M, Kinjo T, Tateyama M, Fujita J. Case Report: Ischemic Enterocolitis Associated with Coronavirus Disease 2019: Two Case Reports and a Review of the Literature. Am J Trop Med Hyg. 2021 Mar 18; 104(5):1655-1658. PMID: 33735103.
      Citations: 1     Fields:    
    6. Hoshino K, Maeshiro T, Nishida N, Sugiyama M, Fujita J, Gojobori T, Mizokami M. Transmission dynamics of SARS-CoV-2 on the Diamond Princess uncovered using viral genome sequence analysis. Gene. 2021 May 05; 779:145496. PMID: 33588037.
      Citations:    Fields:    Translation:HumansPHPublic Health
    7. Nakamura H, Ouchi G, Miyagi K, Higure Y, Otsuki M, Nishiyama N, Kinjo T, Nakamatsu M, Tateyama M, Kukita I, Fujita J. Case Report: Iliopsoas Hematoma during the Clinical Course of Severe COVID-19 in Two Male Patients. Am J Trop Med Hyg. 2021 Jan 13; 104(3):1018-1021. PMID: 33534775.
      Citations: 3     Fields:    
    8. Fujita J. Mycoplasma pneumoniae pneumonia and respiratory syncytial virus infection in Japan during the severe acute respiratory syndrome coronavirus 2 pandemic. Respir Investig. 2021 01; 59(1):5-7. PMID: 33279448.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    9. Sunagawa S, Iha Y, Kinjo T, Nakamura K, Fujita J. Disappearance of summer influenza in the Okinawa prefecture during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Respir Investig. 2021 Jan; 59(1):149-152. PMID: 33246913.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    10. Nakamura H, Miyagi K, Otsuki M, Higure Y, Nishiyama N, Kinjo T, Nakamatsu M, Haranaga S, Tateyama M, Fujita J. Use of the interleukin 6 inhibitor tocilizumab in Japanese patients with cytokine release syndrome caused by COVID-19-related acute respiratory distress syndrome: A case series. Respir Investig. 2020 11; 58(6):510-512. PMID: 33067149.
      Citations:    Fields:    Translation:Humans
    11. Fujita J. SARS-CoV-2 as a causative agent of idiopathic interstitial pneumonia and interstitial pneumonia associated with collagen vascular disorders. Respir Investig. 2020 11; 58(6):427-429. PMID: 33032954.
      Citations:    Fields:    Translation:Humans
    12. Nakamura H, Miyagi K, Otsuki M, Higure Y, Nishiyama N, Kinjo T, Nakamatsu M, Haranaga S, Tateyama M, Fujita J. Acute Hypertriglyceridaemia Caused by Tocilizumab in a Patient with Severe COVID-19. Intern Med. 2020 Nov 15; 59(22):2945-2949. PMID: 32963155.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    13. Nakamura H, Kinjo T, Arakaki W, Miyagi K, Tateyama M, Fujita J. Serum levels of receptor-interacting protein kinase-3 in patients with COVID-19. Crit Care. 2020 08 04; 24(1):484. PMID: 32753065.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    14. Nakamura H, Miyagi K, Otsuki M, Higure Y, Nishiyama N, Kinjo T, Nakamatsu M, Haranaga S, Tateyama M, Fujita J. Serum KL-6 can distinguish between different phenotypes of severe COVID-19. J Med Virol. 2021 01; 93(1):158-160. PMID: 32633842.
      Citations: 3     Fields:    Translation:Humans
    Fujita's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (329)
    Explore
    _
    Co-Authors (41)
    Explore
    _
    Similar People (60)
    Explore
    _